TowfighiA, ZhengL, OvbiageleB. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med, 2009; 169:1762–1766.
2.
ChouA, ScholleS, WeismanC. Process-of-care variables may explain some of the male-female differences in cardiovascular disease outcomes. Womens Health Issues, 2007; 17:120–130.
3.
ChouAF, WongL, WeismanCSet al.Commercial health plans show disparities between women and men in cardiovascular care. Womens Health Issues, 2007; 17:139–149.
4.
DeFaria YehD, FreemanMW, MeigsJB, GrantRW. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol. Am J Cardiol, 2007; 99:1–4.
5.
Correa-de-AraujoR, StevensB, MoyE, NilasenaD, ChesleyF, McDermottK. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities. Womens Health Issues, 2006; 16:44–55.
6.
PreglerJ, FreundKM, KleinmanMet al.The Heart Truth Professional Education Campaign on Women and Heart Disease: Needs Assessment and Evaluation Results. J Womens Health, 2009; 18:1541–1547.
7.
Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 2009; 151:474–482.
8.
AndersonJL, AntmanEM, BridgesCRet al.American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2007; 50:e1–e157.
9.
DouglasPS, KhandheriaB, StainbackRFet al.ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR Stress Echocardiography Writing Group. 2008 appropriateness criteria for stress echocardiography: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: Endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. Circulation, 2008; 117:1478–1497.
10.
EpsteinAE, DiMarcoJP, EllenbogenKAet al.ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation, 2008; 117:e350–408.
11.
FleisherLA, BeckmanJA, BrownKAet al.Writing committee members. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2009; 120:e169–276.
12.
HivertM-F, GrantR, ShraderP, MeigsJ. Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records. BMC Health Serv Res, 2009; 9:170.
13.
JessupM, AbrahamWT, CaseyDEet al.Writing group to review new evidence and update the guideline for the management of patients with chronic heart failure on behalf of the Heart Failure Writing Committee 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009; 119:1977–2016.
14.
MoscaL, BankaCL, BenjaminEJet al.Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Col Cardiol, 2007; 49:1230–1250.
15.
Lloyd-JonesD, AdamsR, CarnethonMet al.Heart disease and stroke statistics 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2009; 119:e21–e181.
16.
GrundySM, CleemanJI, DanielsSRet al.Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, 2005; 112:2735–2752.
17.
HelfandM, BuckleyDI, FreemanMet al.Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med, 2009; 151:496–507.
18.
MoscaL, MansonJE, SutherlandSE, LangerRD, ManolioT, Barrett-ConnorE. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association. Circulation, 1997; 96:2468–2482.
19.
RidkerPM, DanielsonE, FonsecaFAHet al.Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008; 359:2195–2207.
20.
BuckleyDI, FuR, FreemanM, RogersK, HelfandM. C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med, 2009; 151:483–495.
21.
BlumA, BlumN. Coronary artery disease: Are men and women created equal?Gend Med, 2009; 6:410–418.
22.
FanJ, WatanabeT. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscleros Thromb, 2003; 10:63–71.
Van DykeT. Control of inflammation and periodontitis. Periodontology 2000, 2007; 45:158–166.
25.
CrewKD, ShaneE, CremersS, McMahonDJ, IraniD, HershmanDL. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol, 2009; 27:2151–2156.
26.
HeaneyRP. Vitamin D in health and disease. Clin J Am Soc Nephrol, 2008; 3:1535–1541.
27.
ZittermannA. Vitamin D in preventive medicine: Are we ignoring the evidence?Br J Nutr, 2003; 89:552–572.
28.
PencinaMJ, D'AgostinoRBSr., LarsonMG, MassaroJM, VasanRS. Predicting the 30-year risk of cardiovascular disease: The Framingham Heart Study. Circulation, 2009; 119:3078–3084.
29.
Bischoff-FerrariHA, Dawson-HughesB, HathcockJ, GiovannucciE, WillettWC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int, December3, 2009Epub ahead of print.2009 December 14.
30.
GrantWB. A report of the IARC Working Group. A critical review of vitamin D and cancer. Dermatoendocrinology, 2009; 1:25–33.
31.
BellamyL, CasasJ-P, HingoraniAD, WilliamsDJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systemic review and meta-analysis. BMJ, 2007; 335:974–975.
32.
RetnakaranR, YingQ, ZinmanB, SermerM, HanleyA, ConnellyP. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab, 2010; 95:670–677.
33.
BarthJr, VolzA, SchmidJ-Pet al.Gender differences in cardiac rehabilitation outcomes: Do women benefit equally in psychological health?J Womens Health, 2009; 18:2033–2039.
34.
LichtmanJH, BiggerJT.Jr, BlumenthalJAet al.Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation, 2008; 118:1768–1775.
35.
Rajendra HMehta, PetersonED, CaliffRM. Performance measures have a major effect on cardiovascular outcomes: A review. Am J Med, 2007; 120:398–402.
36.
de SimoneG, DevereuxR, ChinaliMet al.Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens, October19, 2009[Epub ahead of print]2009 December 18.
37.
CaliffR, BoolellM, HaffnerSet al.NAVIGATOR Study Group. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. Am Heart J, 2008; 156:623–632.
38.
Lloyd-JonesD, AdamsRJ, BrownTMet al.Heart disease and stroke statistics—2010 update. A report from the American Heart Association. Circulation, 2009Published online December 17, 20092010 January 7.
39.
MehnerA, LindbladU, RåstamL, BoströmKB. Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men: The Skaraborg Hypertension and Diabetes Project. Eur J Clin Pharmacol, 2008; 64:815–820.
40.
BudnickK, CampbellJ, EsauL, LyonsJ, RogersN, HaennelR. Cardiac rehabilitation for women: A systematic review. Can J Cardiovasc Nurs, 2009; 19:13–25.
41.
KingML, LichtmanSW. Underutilization of cardiac rehabilitation: Unique challenges for women. Curr Cardiovasc Risk Rep, 2009; 3:226–231.
42.
BeckieTM, BecksteadJW, GroerMW. The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. J Cardiovasc Nurs, November2009[Epub ahead of print]2009 January 6.
43.
LichtensteinAH, AppelLJ, BrandsMet al.Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation, 2006; 114:82–96.
44.
RudkowskaI. Functional foods for cardiovascular disease in women. Menopause Int, 2008; 14:63–69.
45.
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001; 285:2486–2497.
46.
LeeJH, O'KeefeJH, LavieCJ, MarchioliR, HarrisWS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc, 2008; 83:324–332.
47.
ThorpAA, HowePRC, MoriTAet al.Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. Am J Clin Nutr, 2008; 88:298–304.
48.
ChiuveSE, RexrodeKM, SpiegelmanD, LogroscinoG, MansonJE, RimmEB. Primary prevention of stroke by healthy lifestyle. Circulation, 2008; 118:947–954.
49.
ShufeltC, Bairey MerzC. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol, 2009; 53:221–231.
50.
AnthonisenNR, SkeansMA, WiseRA, ManfredaJ, KannerRE, ConnettJE. Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: A randomized clinical trial. Ann Intern Med, 2005; 142:233–239.
